Search


BIO International 2025: eGenesis CEO Mike Curtis discusses the case of the second patient who has received a transplant using the company's genetically engineered porcine kidney, and what is next
He describes the successful transplant of Tim Andrews, who threw out the first pitch at a Red Socks game last week, and discusses what is...
Jun 16


The CEO of eGenesis elaborates on today's Nature paper using pig kidneys for transplantation in NHPs
Mike Curtis explains how transplanted pig kidneys have shown durability (over two years) in some non-human primates.
Oct 11, 2023








.png)




